Curaleaf Holdings (TSX:CURA) Interest Expense: C$-139 Mil (TTM As of Mar. 2026)

What is Curaleaf Holdings Interest Expense?

Curaleaf Holdings TSX:CURA -9.08% 76 Interest Expense is C$-139 Mil as of Mar. 2026. GuruFocus rates TSX:CURA with a GF Score™ of 76/100 and a GF Value™ of C$11.39 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Curaleaf Holdings's interest expense for the three months ended in Mar. 2026 was C$ -35 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2026 was C$-139 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Curaleaf Holdings's Operating Income for the three months ended in Mar. 2026 was C$ 1 Mil. Curaleaf Holdings's Interest Expense for the three months ended in Mar. 2026 was C$ -35 Mil. Curaleaf Holdings's Interest Coverage for the quarter that ended in Mar. 2026 was 0.03. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Curaleaf Holdings (TSX:CURA) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Curaleaf Holdings's Interest Expense for the three months ended in Mar. 2026 was C$-35 Mil. Its Operating Income for the three months ended in Mar. 2026 was C$1 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2026 was C$1,043 Mil.

Curaleaf Holdings's Interest Coverage for the quarter that ended in Mar. 2026 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2026 )	/	Interest Expense (Q: Mar. 2026 )
	=	-1	*	1.033	/	-35.023
	=	0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Curaleaf Holdings Interest Expense Historical Data

* Premium members only.

The historical data trend for Curaleaf Holdings's Interest Expense can be seen below:

Curaleaf Holdings Interest Expense Chart

Curaleaf Holdings Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

Interest Expense

Get a 7-Day Free Trial

-115.54

-120.69

-134.67

-143.35

-139.09

Curaleaf Holdings Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Interest Expense	Get a 7-Day Free Trial															-36.24	-35.15	-35.09	-33.80	-35.02

76GF Score

Curaleaf Holdings Inc TSX:CURA

Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Curaleaf Holdings Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-139 Mil.

Frequently Asked Questions Learn more about Interest Expense →

What does a Interest Expense of C$-139 Mil mean?

Curaleaf Holdings (TSX:CURA) has a Interest Expense of C$-139 Mil as of Mar. 2026. Interest Expense is the amount a company pays on its long-term debt. View historical data on Curaleaf Holdings and its competitors.

Is Curaleaf Holdings' Interest Expense too high?

Curaleaf Holdings' current Interest Expense is C$-139 Mil. Overall, Curaleaf Holdings has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Curaleaf Holdings' Interest Expense compare to ZTS and UTHR?

Curaleaf Holdings' Interest Expense of C$-139 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Interest Expense for a Drug Manufacturers company?

A good Interest Expense depends on the Drug Manufacturers industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Interest Expense mean?

A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on Curaleaf Holdings and its competitors. Curaleaf Holdings's current Interest Expense is C$-139 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Curaleaf Holdings stock overvalued right now?

Based on GuruFocus' analysis, Curaleaf Holdings (TSX:CURA) is currently considered Modestly Overvalued. The stock's GF Value™ is C$11.39, compared to a current price of C$13.32 — trading 16.9% above its estimated fair value. The current Interest Expense is C$-139 Mil. Curaleaf Holdings' overall GF Score™ is 76/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Interest Expense calculated?

Interest Expense is calculated from a company's financial statements. For Curaleaf Holdings (TSX:CURA), the current Interest Expense is C$-139 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Curaleaf Holdings (TSX:CURA) Overvalued in 2026?

Based on GuruFocus' analysis, Curaleaf Holdings stock appears to be overvalued. The current stock price of C$13.32 is trading 16.9% above its estimated GF Value™ of C$11.39. GuruFocus considers Curaleaf Holdings to be Modestly Overvalued.

Key valuation signals for TSX:CURA:

Interest Expense: C$-139 Mil
GF Value™: C$11.39 vs. price of C$13.32 (16.9% above fair value)
GF Score™: 76/100 with 5 warning signs

No single metric tells the full story. See the TSX:CURA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Curaleaf Holdings Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies TSX:BHC XCNQ:GTII TSX:CRON NEOE:GLAS.A.U TSX:DHT.U TSX:GUD XCNQ:VREO NEOE:VRNO TSX:WEED XCNQ:CL XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges CURLD:USA 2XW:Germany

Address 290 Harbor Drive, Stamford, CT, USA, 06902

Website https://www.curaleaf.com

Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the US. The company has operations in 17 states. Its brands include Curaleaf, Select, and Grassroots. The company has made acquisitions that give it exposure to the growing European market, a unique feature among US multistate operators.

76GF Score

Get the complete analysis for TSX:CURA

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

C$13.32

Price

C$11.39

GF Value

View TSX:CURA Analysis

See Interest Expense data for all stocks →